Robaxin vs. Tizanidine
See how Robaxin and Tizanidine compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Robaxin treats muscle spasms from acute injuries, while tizanidine is FDA-approved specifically for spasticity from conditions like multiple sclerosis or spinal cord injury.
Tizanidine causes dry mouth, sedation, and weakness in more than 10% of users, while Robaxin's most common side effects are dizziness, drowsiness, headache, and nausea without specific rates listed.
Tizanidine requires liver monitoring and carries drug interaction risks that Robaxin does not, but Robaxin needs more frequent daily dosing during the first few days of treatment.
Robaxin vs. Tizanidine Drug Summary
Robaxin
Robaxin (methocarbamol) is a centrally-acting skeletal muscle relaxant used alongside rest and physical therapy for acute, painful musculoskeletal conditions. It comes as an oral tablet or an IV/IM injection, with the injectable form also used as adjunct therapy for tetanus. Robaxin has been on the market since 1957 and is not a federally controlled substance.
Tizanidine
Tizanidine is a centrally acting alpha-2 adrenergic agonist approved to manage spasticity from conditions like multiple sclerosis or spinal cord injury. It is taken orally as a tablet or capsule, with doses gradually increased over days to find an effective level. It is also used off-label for chronic pain and migraine prevention, though these uses are not FDA-approved.
Robaxin vs. Tizanidine Side Effects
Robaxin
Tizanidine
Robaxin vs. Tizanidine Dosage
Robaxin
Tizanidine
| STAGE | DOSE | WHEN |
| Starting dose | 1500 mg four times daily | Days 1-3 |
| Maximum dose | 1000 mg IM/IV per dose | If needed |
| Dose changes | 2 increases | Every 3 days |
| STAGE | DOSE | WHEN |
| Starting dose | 2 mg every 6-8 hrs | At the start |
| Maximum dose | Up to 36 mg/day | If needed |
| Dose changes | 2 increases | As tolerated |
Robaxin
| STAGE | DOSE | WHEN |
| Starting dose | 1500 mg four times daily | Days 1-3 |
| Maximum dose | 1000 mg IM/IV per dose | If needed |
| Dose changes | 2 increases | Every 3 days |
Tizanidine
| STAGE | DOSE | WHEN |
| Starting dose | 2 mg every 6-8 hrs | At the start |
| Maximum dose | Up to 36 mg/day | If needed |
| Dose changes | 2 increases | As tolerated |
Robaxin vs. Tizanidine Indications
Robaxin
Robaxin is approved as an adjunct to rest and physical therapy for pain from acute musculoskeletal injuries, like a strained back or pulled muscle. The injectable form is also used to help manage muscle spasms in tetanus. It is not intended for long-term or chronic pain management.
Acute, painful musculoskeletal conditions
Adjunct to rest and physical therapy
Adjunctive treatment in tetanus (injectable form)
Short-term use only, not for chronic conditions
Tizanidine
Tizanidine is FDA-approved specifically for spasticity, the muscle tightness and spasms seen in conditions like multiple sclerosis or spinal cord injury. It is also used off-label for chronic low back pain, myofascial pain, and migraine prevention, though these uses are not FDA-approved. Its formulations should not be swapped, since tablets and capsules absorb differently.
Spasticity from multiple sclerosis or spinal cord injury (FDA-approved)
Chronic low back or myofascial pain (off-label)
Migraine prevention (off-label)
Insomnia (off-label)
Robaxin vs. Tizanidine Pros and Cons
Robaxin
Robaxin has a long track record dating back to 1957 and offers both oral and injectable options, which is useful for patients who need rapid relief or cannot take pills. It has fewer major drug interaction warnings than tizanidine, but its dosing schedule during the first few days is more demanding.
Pros
Long-standing safety record spanning decades of clinical use
Available as both oral tablets and an IV/IM injection
No major contraindicated drug interactions listed on its label
Approved for use as adjunct therapy in tetanus
Cons
Requires four-times-daily dosing during initial treatment days
Specific side effect rates aren't quantified in FDA labeling
Not approved for spasticity or neurological muscle tightness
Reports of fetal abnormalities with in utero exposure
Tizanidine
Tizanidine is the more targeted option for spasticity, with a flexible titration schedule that lets doses be adjusted every few days. It carries more serious monitoring requirements, including liver function checks and blood pressure risks, especially in combination with other medications.
Pros
FDA-approved specifically for spasticity, not just general muscle pain
Flexible titration schedule allows gradual, individualized dosing
Widely used off-label for chronic pain and migraine prevention
Lower starting dose may mean a gentler initial side effect profile
Cons
Requires periodic liver function monitoring due to hepatotoxicity risk
Can cause significant hypotension or bradycardia, especially with other blood pressure medications
Contraindicated with fluvoxamine and ciprofloxacin
Stopping abruptly after prolonged high-dose use can trigger rebound hypertension
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.